EZH2 and mantle cell lymphoma: CDK1 is downregulated in FGFR1 inhibition/loss in MCL cells (Fig. 6J-K) and restored by EZH2 overexpression (Fig. 6L) or CDKN1C downregulation (Fig. 6M) in erdafitinib treated MCL cells.